Abstract
Efavirenz is an anti-HIV drug categorized under Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). It is recognized as the first line drug of choice for treating HIV infections. Poor aqueous solubility of the drug (< 10 µg/mL) offers specific challenges in formulation design, leading to limited bioavailability of 40 to 50%. To address this issue, several drug delivery options have been adopted for Efavirenz with special emphasis on alternative routes of administration like buccal, rectal, vaginal and transdermal. The carrier-based delivery using vesicular systems, micro/nanoparticles, hydrogels, degradable systems, etc. was also designed through solvent evaporation, spray drying, double emulsification and ionic gelation techniques. The nanotechnology-based drug delivery approaches have been demonstrated with significant improvement in the solubility and bioavailability of Efavirenz. The objective of the review is to compile and present the comprehensive report of various researches highlighted for synthesizing nanoparticles of Efavirenz using different polymeric and nonpolymeric materials. We have discussed the range of materials utilized for the preparation of stable nanoparticles through the validated experimental protocol and their substantial selection of optimized formulation through significant results.
Keywords: Efavirenz, dissolution, solubility, nanoparticles, polymer, HIV.
Current Organic Chemistry
Title:Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz
Volume: 22 Issue: 27
Author(s): K. Priya Dharshini, D. Ramya Devi and B.N. Vedha Hari*
Affiliation:
- Department of Pharmacy, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur- 613401,India
Keywords: Efavirenz, dissolution, solubility, nanoparticles, polymer, HIV.
Abstract: Efavirenz is an anti-HIV drug categorized under Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). It is recognized as the first line drug of choice for treating HIV infections. Poor aqueous solubility of the drug (< 10 µg/mL) offers specific challenges in formulation design, leading to limited bioavailability of 40 to 50%. To address this issue, several drug delivery options have been adopted for Efavirenz with special emphasis on alternative routes of administration like buccal, rectal, vaginal and transdermal. The carrier-based delivery using vesicular systems, micro/nanoparticles, hydrogels, degradable systems, etc. was also designed through solvent evaporation, spray drying, double emulsification and ionic gelation techniques. The nanotechnology-based drug delivery approaches have been demonstrated with significant improvement in the solubility and bioavailability of Efavirenz. The objective of the review is to compile and present the comprehensive report of various researches highlighted for synthesizing nanoparticles of Efavirenz using different polymeric and nonpolymeric materials. We have discussed the range of materials utilized for the preparation of stable nanoparticles through the validated experimental protocol and their substantial selection of optimized formulation through significant results.
Export Options
About this article
Cite this article as:
Dharshini Priya K. , Devi Ramya D. and Hari Vedha B.N.*, Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz, Current Organic Chemistry 2018; 22 (27) . https://dx.doi.org/10.2174/1385272822666181116122616
DOI https://dx.doi.org/10.2174/1385272822666181116122616 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV Genes Diversify in B Cells
Current HIV Research Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
Current Alzheimer Research Recent Patents Review on Intranasal Administration for CNS Drug Delivery
Recent Patents on Drug Delivery & Formulation Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Current Drug Targets Biologics and the Cardiovascular System: A Double-Edged Sword
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
Current Alzheimer Research Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment
Current Alzheimer Research Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies
Current Pharmaceutical Design The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance
Current Molecular Medicine Alzheimers Disease and P300: Review and Evaluation of Task and Modality
Current Alzheimer Research Processing of Amyloid Precursor Protein as a Biochemical Link Between Atherosclerosis and Alzheimers Disease
Cardiovascular & Hematological Disorders-Drug Targets The Mechanism of Memory Impairment Induced by Aβ Chronic Administration Involves Imbalance between Cytokines and Neurotrophins in the Rat Hippocampus
Current Alzheimer Research Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
Current Neuropharmacology Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Marking the Centennial of Alzheimers First Report of the Disease with a Perspective of Ongoing Research and Future Challenge
Current Alzheimer Research Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
CNS & Neurological Disorders - Drug Targets Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design Cellular Senescence as a Target in Cancer Control
Current Cancer Therapy Reviews